MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ZS Pharma Company Profile (NASDAQ:ZSPH)

Consensus Ratings for ZS Pharma (NASDAQ:ZSPH) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $69.75 (35.33% upside)

Analysts' Ratings History for ZS Pharma (NASDAQ:ZSPH)
Show:
DateFirmActionRatingPrice TargetActions
8/13/2015Morgan StanleyInitiated CoverageOverweight$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/9/2015JPMorgan Chase & Co.Reiterated RatingOverweight$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2015Credit SuisseReiterated RatingOutperform$58.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015BMO Capital MarketsReiterated RatingOutperform$54.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015JPMorgan Chase & Co.Boost Price TargetOverweight$57.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015JPMorgan Chase & Co.Reiterated RatingOverweight$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015JPMorgan Chase & Co.Reiterated RatingOverweight$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014BMO Capital MarketsBoost Price TargetOutperform$45.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Credit SuisseBoost Price Target$51.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014Credit SuisseInitiated CoverageOutperform$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014William BlairInitiated CoverageOutperform$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014JPMorgan Chase & Co.Initiated CoverageOverweight$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014BMO Capital MarketsInitiated CoverageOutperform$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha